In January, the FDA posted 12 Form 483s and one untitled letter to compounding/outsourcing facilities. We list them below.

And, we reviewed the FDAzill a Store to see which 483s were most-purchased and trending during January.

483s to Compounding/Outsourcing Facilities

Abilene Nuclear LLC

Abilene Nuclear LLC (Abilene, TX) received a form 483 at the end of an inspection ending November 7, 2019.

Apex Pharmacy LLC

Apex Pharmacy LLC (Beckley, WV) received a form 483 at the close of inspection on November 7, 2019.

Auro Pharmacies

Auro Pharmacies (La Habra, CA) received a form 483 at the close of inspection on October 18, 2019.

Avenue Pharmacy Inc

Avenue Pharmacy Inc (Ocala, FL) received a form 483 at the close of inspection on December 6, 2019.

Lloyd Central Compounding Pharmacy

Lloyd Central Compounding Pharmacy (Portland, OR) received a form 483 issued at the close of inspection on November 26, 2019.

McGuff Compounding Pharmacy Services Inc.

McGuff Compounding Pharmacy Services Inc. (Santa Ana, CA) received a form 483 at the close of inspection on November 22, 2019.

MPRX Inc

MPRX Inc (Dallas, TX) received a form 483 at the close of inspection on November 22, 2019.

Pharmaview, Inc.

Pharmaview, Inc. (Bedminster, NJ) received a form 483 issued at the close of inspection on November 14, 2019.

Randol Mill Pharmacy

Randol Mill Pharmacy (Arlington, TX) received a form 483 at the close of inspection on August 6, 2019.

Right Value Drug Store, Inc (dba Carie Boyd’s Prescription Shop)

Right Value Drug Store, Inc (dba Carie Boyd’s Prescription Shop) (Hurst, TX) received an untitled letter on October 25, 2019. The firm compounded drugs that were not eligible for this activity. Some products did not include complete information on the container to permit adverse event reporting. The firm did not notify the FDA which drug products they compounded as required. Further, the company distributes unapproved new drugs and misbranded drugs.